First human test for new drug begins
NCT ID NCT07352423
Summary
This is an early safety study for a new drug called ALXN2230. It will test single injections in 48 healthy adult volunteers to see how safe it is and how the body handles it. The main goal is to check for side effects and measure the drug's levels in the blood over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
London, NW10 7EW, United Kingdom
Conditions
Explore the condition pages connected to this study.